Crispr Therapeutics AG vs Packaging Corporation of America — how do they compare? Crispr Therapeutics AG trades at $50.76 (market cap $4.99B), while Packaging Corporation of America trades at $226.04 (market cap $20.12B). The key difference: Packaging Corporation of America is far larger — about 4× Crispr Therapeutics AG's market cap, and Packaging Corporation of America pays a 2.66% dividend while Crispr Therapeutics AG pays none. Which is the better fit depends on your goals.
| CRSP | PKG | |
|---|---|---|
Market Cap | $4.99B | $20.12B |
Sector | Health | Technology |
52-Week High | $76.78 | $246.31 |
52-Week Low | $44.34 | $191.41 |
Enterprise Value | $3.33B | $23.95B |
Dividend Yield | — | 2.66% |
Trailing returns across standard periods
CRISPR Therapeutics is a gene editing company focused on the development of CRISPR/Cas9-based therapeutics. CRISPR/Cas9 stands for Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9), which is a revolutionary technology for precisely altering specific sequences of genomic DNA. The company is focused on using this technology to treat genetically defined diseases. CRISPR's most advanced pipeline candidate, CTX001, is in collaboration with Vertex Pharmaceuticals and targets sickle cell disease and transfusion-dependent beta-thalassemia, which have high unmet medical needs. The company is progressing additional gene editing programs for immuno-oncology, as well as a stem cell-derived therapy for the treatment of Type 1 diabetes.
Read more on CRSP →Packaging Corporation of America is a leading producer of containerboard and corrugated packaging products in North America. The company also produces white papers, which include printing and writing papers. PKG operates as an integrated manufacturer, with a strong focus on high-quality and sustainable packaging solutions for e-commerce, food and beverage, and other industrial and consumer markets.
Read more on PKG →